227 related articles for article (PubMed ID: 9422538)
41. Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma.
Bansal D; Pasricha S; Gupta G; Sharma A; Durga G; Kamboj M; Mehta A
Indian J Pathol Microbiol; 2024; 67(1):141-144. PubMed ID: 38358204
[TBL] [Abstract][Full Text] [Related]
42. CD21 antigen in T-lineage neoplastic lymphoid cells: characteristic expression at thymic stage.
Tatsumi E; Yoneda N; Kawano S; Yamaguchi N
Am J Hematol; 1994 Feb; 45(2):150-5. PubMed ID: 7511331
[TBL] [Abstract][Full Text] [Related]
43. Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma.
Nagel S; Leich E; Quentmeier H; Meyer C; Kaufmann M; Drexler HG; Zettl A; Rosenwald A; MacLeod RA
Leukemia; 2008 Feb; 22(2):387-92. PubMed ID: 17989712
[TBL] [Abstract][Full Text] [Related]
44. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
[TBL] [Abstract][Full Text] [Related]
45. Cysteine protease CPP32, but not Ich1-L, is expressed in germinal center B cells and their neoplastic counterparts.
Xerri L; Devilard E; Ayello C; Brousset P; Reed JC; Emile JF; Hassoun J; Parmentier S; Birg F
Hum Pathol; 1997 Aug; 28(8):912-21. PubMed ID: 9269827
[TBL] [Abstract][Full Text] [Related]
46. Differential expression of WT1 gene product in non-Hodgkin lymphomas.
Drakos E; Rassidakis GZ; Tsioli P; Lai R; Jones D; Medeiros LJ
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):132-7. PubMed ID: 15894924
[TBL] [Abstract][Full Text] [Related]
47. Expression of oncoprotein 18 in human leukemias and lymphomas.
Roos G; Brattsand G; Landberg G; Marklund U; Gullberg M
Leukemia; 1993 Oct; 7(10):1538-46. PubMed ID: 8412315
[TBL] [Abstract][Full Text] [Related]
48. CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkin's lymphomas.
Wolowiec D; Berger F; Ffrench P; Bryon PA; Ffrench M
Leuk Lymphoma; 1999 Sep; 35(1-2):147-57. PubMed ID: 10512172
[TBL] [Abstract][Full Text] [Related]
49. Flow cytometry in the diagnosis of mediastinal tumors with emphasis on differentiating thymocytes from precursor T-lymphoblastic lymphoma/leukemia.
Gorczyca W; Tugulea S; Liu Z; Li X; Wong JY; Weisberger J
Leuk Lymphoma; 2004 Mar; 45(3):529-38. PubMed ID: 15160915
[TBL] [Abstract][Full Text] [Related]
50. Expression of classical protein kinase C subspecies in non-neoplastic lymphocytes and non-Hodgkin's lymphomas: an immunohistochemical study.
Hojo H; Morimura Y; Abe M; Wakasa H
Pathol Int; 1996 Feb; 46(2):148-54. PubMed ID: 10846563
[TBL] [Abstract][Full Text] [Related]
51. CDK6: an attractive therapeutic target for T-ALL/LBL.
Li W; Hu JK; Hu MG
Expert Opin Ther Targets; 2023; 27(11):1087-1096. PubMed ID: 37975616
[TBL] [Abstract][Full Text] [Related]
52. Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis.
Gary JM; Simmons JK; Xu J; Zhang S; Peat TJ; Watson N; Gamache BJ; Zhang K; Kovalchuk AL; Michalowski AM; Chen JQ; Thaiwong T; Kiupel M; Gaikwad S; Etienne M; Simpson RM; Dubois W; Testa JR; Mock BA
Mol Cancer Ther; 2020 Oct; 19(10):2221-2232. PubMed ID: 32747423
[TBL] [Abstract][Full Text] [Related]
53. CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia.
Jena N; Sheng J; Hu JK; Li W; Zhou W; Lee G; Tsichlis N; Pathak A; Brown N; Deshpande A; Luo C; Hu GF; Hinds PW; Van Etten RA; Hu MG
Leukemia; 2016 May; 30(5):1033-43. PubMed ID: 26707936
[TBL] [Abstract][Full Text] [Related]
54. Expression of p53 in pediatric lymphomas from Mexico.
Venkatesh H; Mezacoria C; Lopezcorella E; Ridaurasanz C; Oconor G; Luna R; Bhatia K; Magrath I
Int J Oncol; 1997 Sep; 11(3):477-80. PubMed ID: 21528235
[TBL] [Abstract][Full Text] [Related]
55. A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis.
Hu MG; Deshpande A; Enos M; Mao D; Hinds EA; Hu GF; Chang R; Guo Z; Dose M; Mao C; Tsichlis PN; Gounari F; Hinds PW
Cancer Res; 2009 Feb; 69(3):810-8. PubMed ID: 19155308
[TBL] [Abstract][Full Text] [Related]
56. Expression of the promyelocytic leukemia zinc-finger in T-lymphoblastic lymphoma and leukemia has strong implications for their cellular origin and greater association with initial bone marrow involvement.
Jeon YK; Go H; Nam SJ; Keam B; Kim TM; Jung KC; Kang HJ; Lee DS; Huh JR; Park SH
Mod Pathol; 2012 Sep; 25(9):1236-45. PubMed ID: 22555178
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.
Chen D; Law ME; Theis JD; Gamez JD; Caron LB; Vrana JA; Dogan A
Am J Surg Pathol; 2009 May; 33(5):720-9. PubMed ID: 19145199
[TBL] [Abstract][Full Text] [Related]
58. [Expression of CDK6 and FOXM1 in peripheral T-cell lymphoma and their significance].
Feng HN; Shao XX; Bu P; Zhang F; Wang YJ; Xi YF; Guo WN
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):594-600. PubMed ID: 32486537
[No Abstract] [Full Text] [Related]
59. Bcl-2 maturation pattern in T-cells distinguishes thymic neoplasm/hyperplasia, T-lymphoblastic lymphoma, and reactive lymph nodes.
Ward N; Baqai J; Zehnpfennig A; Fine N; Huang J; Smith MD
Cytometry B Clin Cytom; 2018 May; 94(3):444-450. PubMed ID: 28718205
[TBL] [Abstract][Full Text] [Related]
60. Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets.
Lin YW; Aplan PD
Leukemia; 2007 Jun; 21(6):1276-84. PubMed ID: 17429429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
